about
PIAS1 interacts with FLASH and enhances its co-activation of c-MybThe mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancerIn vivo conditional Pax4 overexpression in mature islet β-cells prevents stress-induced hyperglycemia in mice.PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus.Loss of lysosomal membrane protein NCU-G1 in mice results in spontaneous liver fibrosis with accumulation of lipofuscin and iron in Kupffer cells.Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation.Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors.The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis.A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitmentPAX4 Defines an Expandable β-Cell Subpopulation in the Adult Pancreatic Islet.Thyroid hormone-dependent regulation of Talpha1 alpha-tubulin during brain development.Identification of c-Myb Target Genes in K562 Cells Reveals a Role for c-Myb as a Master Regulator.Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants.Isolation and identification of bacteria from spent nuclear fuel pools.Pax8 Detection in Well-Differentiated Pancreatic Endocrine TumorsBiofouling on the Walls of a Spent Nuclear Fuel Pool with Radioactive Ultrapure WaterTherapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus
P50
Q24293708-6FAC1344-6F96-4715-8B97-DF1158EEA55FQ24314853-723D99E9-DE89-4E83-94D2-2E2E41C8EE38Q35043408-582422A4-DF50-4EF2-A998-82EC31A282CEQ36654026-EE2CDB0A-02C7-4AC8-BD3D-31BDF207E1CBQ37621079-FCBCC0EF-8807-402A-B30E-425C49AB1EC0Q38271452-C1E258B4-2606-4F44-9327-685D37D95BF3Q38698822-4D941DF9-7B48-4E29-8C7E-766DF7E06124Q38731193-1F31AE71-F460-4A23-B9C2-F142C04561F1Q39549745-0FB477BC-B7E5-4101-B32A-CC3037AE92F4Q39715693-194AC03C-9F5E-4C8E-9FA5-76F4BC3A7B00Q40391278-E9B0E244-3C5D-43B7-8357-B8912F9D31BDQ40743462-A951ED5F-C3C2-41CB-8175-453E7F686E1DQ41094888-5603E94C-859D-4D8A-9833-E671C8376D8CQ45045822-D96B101D-A271-4247-B1FC-15D462F263FBQ48145789-08A9D63D-CCC8-4940-B670-15BC0136EE4FQ60175890-8828D607-7271-4474-B6DE-BA4DD15AF9D6Q60175891-8EE0603C-1755-47CD-ACD3-A1A47214FA40Q90505231-D0270383-F65C-4398-81AF-931C0F398087
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Petra I Lorenzo
@nl
Petra I Lorenzo
@sl
Petra I. Lorenzo
@en
Petra I. Lorenzo
@es
type
label
Petra I Lorenzo
@nl
Petra I Lorenzo
@sl
Petra I. Lorenzo
@en
Petra I. Lorenzo
@es
prefLabel
Petra I Lorenzo
@nl
Petra I Lorenzo
@sl
Petra I. Lorenzo
@en
Petra I. Lorenzo
@es
P106
P1153
7005830904
P21
P31
P496
0000-0002-3926-6514